VEON
VEON Ltd.
There isn't enough reported data to score VEON yet.
VEON Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Healthy |
VEON's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
VEON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.5x | $63.62 | -15% |
| Fair | 8.5x | $83.40 | +11% |
| Current | 9.8x | $75.15 | โ |
| Expensive | 10x | $103 | +37% |
Historical ranges are pointers, not guarantees.
VEON's PE is 9.8x, but its earnings don't support one, so it isn't a reliable read right now.
VEON Forward outlook
There aren't enough analyst estimates for VEON to show an outlook.
VEON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $9.82 | +409% |
| Q2 2025 | $10.07 | +$10.08 |
| Q1 2025 | $2.53 | -2.3% |
| Q4 2024 | $1.93 | -71% |
| Q4 2023 | $6.67 | +$8.92 |
| Q4 2022 | -$2.25 | -123% |
| Q4 2021 | $9.75 | +$14.73 |
| Q4 2020 | -$4.98 | -155% |
VEON has returned to profit: it earned $9.82 per share over the past year, after losing money the year before.
VEON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $2.3B | +12% |
| Q2 2025 | $1.1B | +5.8% |
| Q1 2025 | $1B | +8.9% |
| Q4 2024 | $2B | +7.2% |
| Q2 2024 | $1B | +12% |
| Q1 2024 | $942M | +6.6% |
| Q4 2023 | $1.9B | -49% |
| Q4 2022 | $3.8B | -52% |
VEON's revenue is recovering but still below its 2017 peak: $2.3B last quarter, up 123% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 17% | -10 points |
| Q2 2025 | 75% | +54 points |
| Q1 2025 | 23% | -2.1 points |
| Q4 2024 | 31% | +4.6 points |
| Q2 2024 | 27% | +3.9 points |
| Q1 2024 | 21% | -9.6 points |
| Q4 2023 | 25% | +5.6 points |
| Q2 2023 | 26% | +29 points |
VEON's operating margin was 17% last quarter, down 10 points from the same quarter a year ago.
VEON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $408M | +3.6% |
| Q2 2025 | -$48M | -167% |
| Q1 2025 | $255M | +410% |
| Q4 2024 | $394M | -17% |
| Q2 2024 | $72M | -78% |
| Q1 2024 | $50M | -86% |
| Q4 2023 | $476M | +59% |
| Q4 2022 | $299M | -48% |
VEON still generates free cash flow, though less than at its 2016 peak: $1B over the past year.
VEON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | 0.8x | Very low |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.6x | Healthy |
| Q4 2024 | 0.9x | Very low |
| Q2 2024 | 2.1x | Moderate |
| Q1 2024 | 2.0x | Moderate |
| Q4 2023 | 1.1x | Healthy |
| Q4 2022 | 1.8x | Healthy |
VEON's net debt is less than a year of its operating earnings (EBITDA), down from 2.0 years a year ago.
VEON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 70.6 | Neutral |
VEON's weekly RSI is 65 (neutral) and its Stochastic is 71 (neutral).
VEON PE vs Communication Services Sector
| Metric | VEON | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 16x | 41% below |
| PE % | 77 | 26 | 51 pts above |
VEON is trading at 9.8x earnings, a 41% discount to the Communication Services sector's median of 16x, though its earnings don't support one.
VEON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $78.4 | 4.2% below |
| 20 week MA | $66.1 | 14% above |
| 50 week MA | $57.9 | 30% above |
| 100 week MA | $52.9 | 42% above |
| 200 week MA | $37.7 | 100% above |
VEON's trend is up, with a small recent dip: it's below only its 8-week average, and 100% above its 200-week average.
VEON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $63.3 | $40.3 | -36% |
| 2021 | $40.3 | $41.8 | +3.7% |
| 2022 | $41.8 | $11.5 | -72% |
| 2023 | $11.5 | $19.7 | +71% |
| 2024 | $19.7 | $39.0 | +98% |
| 2025 | $39.0 | $52.7 | +35% |
| 2026 YTD | $52.7 | $75.2 | +43% |
VEON has finished higher in four of the last six years, two of them by more than 50%. It's up 43% so far in 2026.